Document Detail

Medical therapy for obesity--current status and future hopes.
MedLine Citation:
PMID:  17964918     Owner:  NLM     Status:  MEDLINE    
In accepting any new drug for the treatment of obesity, the safety profile must make it acceptable for almost everyone. Criteria for selecting treatments involve evaluating the risks to the individual from obesity and balancing that against any possible problems with the treatment. Obesity is a chronic disease that has many causes. Cure is rare and treatment is thus aimed at palliation, that is, producing and maintaining weight loss. Wherever the primary site of action may be, however, the net effect must be a reduction in food intake or an increase in energy expenditure.
George A Bray
Related Documents :
7118358 - Transswitching in the treatment of obesity.
20458548 - The association between obesity and urban food environments.
17449338 - Micronutrient deficiency and the prevalence of mothers' overweight/obesity in egypt.
2086518 - Obesity--a state of reduced sympathetic activity and normal or high adrenal activity (t...
21269008 - Socio-economic status and vitamin/ mineral supplement use in canada.
17965578 - Guidelines for diagnosis and management of pediatric food allergy in japan.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Medical clinics of North America     Volume:  91     ISSN:  0025-7125     ISO Abbreviation:  Med. Clin. North Am.     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-10-29     Completed Date:  2007-12-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985236R     Medline TA:  Med Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1225-53, xi     Citation Subset:  AIM; IM    
Pennington Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Obesity Agents / therapeutic use*
Clinical Trials as Topic
Obesity / drug therapy*
Sympathomimetics / therapeutic use*
Treatment Outcome
Reg. No./Substance:
0/Anti-Obesity Agents; 0/Sympathomimetics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
Next Document:  Bariatric surgery for morbid obesity--a cure for metabolic syndrome?